2.23
price down icon3.88%   -0.09
after-market After Hours: 2.23
loading
Stereotaxis Inc stock is traded at $2.23, with a volume of 182.89K. It is down -3.88% in the last 24 hours and up +9.31% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.32
Open:
$2.33
24h Volume:
182.89K
Relative Volume:
0.68
Market Cap:
$191.78M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-8.2593
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
-1.76%
1M Performance:
+9.31%
6M Performance:
+2.76%
1Y Performance:
+12.63%
1-Day Range:
Value
$2.22
$2.358
1-Week Range:
Value
$2.10
$2.52
52-Week Range:
Value
$1.54
$2.7155

Stereotaxis Inc Stock (STXS) Company Profile

Name
Name
Stereotaxis Inc
Name
Phone
314-678-6100
Name
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Name
Employee
118
Name
Twitter
@stereotaxis
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
STXS
Stereotaxis Inc
2.23 195.22M 25.14M -21.57M -12.23M -0.27
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
516.12 185.10B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
175.33 50.76B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.16 43.19B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
261.07 37.26B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
210.08 16.13B 2.90B 467.20M 306.90M 6.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-24 Initiated ROTH MKM Buy
Jul-12-22 Initiated Aegis Capital Buy
Jun-23-22 Initiated B. Riley Securities Buy
Jan-05-22 Initiated Craig Hallum Buy
Jan-05-22 Initiated Loop Capital Buy
May-26-21 Initiated Piper Sandler Overweight
Sep-08-20 Initiated Northland Capital Outperform
Apr-09-20 Initiated Cowen Outperform
Apr-07-20 Initiated Lake Street Buy
View All

Stereotaxis Inc Stock (STXS) Latest News

pulisher
Jul 21, 2025

What drives Stereotaxis Inc. stock priceConsistently high returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Stereotaxis Inc. a good long term investmentDynamic investment opportunities - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Stereotaxis Inc. stockFree Stock Market Trend Analysis - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Stereotaxis Inc. Stock Analysis and ForecastUnmatched market gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.5% – What’s Next? - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Stereotaxis Publishes Positive Results from MAGiC Catheter Study - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Should I buy Stereotaxis Inc. stock before earningsDaily Swing Candidates - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Stereotaxis Sinks on Common Stock Offering - Baystreet.ca

Jul 17, 2025
pulisher
Jul 17, 2025

Stereotaxis projects second quarter revenue growth and stable margins By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Stereotaxis raises $12.5 million in registered direct offering By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Stereotaxis raises $12.5 million in registered direct offering - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Stereotaxis, Inc. Secures $12.5 Million in Registered Direct Offering to Enhance Balance Sheet and Accelerate Product Commercialization - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

Surgical Robotics Leader Stereotaxis Lands $12.5M Investment from Strategic Industry Partner - Stock Titan

Jul 17, 2025
pulisher
Jul 15, 2025

How Stereotaxis Inc. stock performs during market volatilityFree Daily Stock Market Updates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Concrete Pumping Holdings Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Stereotaxis Inc. stock price move sharplyCapital Doubling Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Stereotaxis Inc. stock attracts strong analyst attentionFree Investment Portfolio Suggestions - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Stereotaxis Pubishes First Clinical Results from MAGiC Catheter Study - Diagnostic and Interventional Cardiology

Jul 10, 2025
pulisher
Jul 10, 2025

Electrophysiology Market is projected to reach USD 22.63 - openPR.com

Jul 10, 2025
pulisher
Jul 09, 2025

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial - MSN

Jul 09, 2025
pulisher
Jul 06, 2025

Stereotaxis at an Inflection Point: Catheter Adoption and GenesisX Drive a New Era of Growth - AInvest

Jul 06, 2025
pulisher
Jul 06, 2025

Stereotaxis Stock: Recurring Revenue Inflection (NYSE:STXS) - Seeking Alpha

Jul 06, 2025
pulisher
Jul 01, 2025

First Clinical Results: Revolutionary MAGiC Robotic Catheter Achieves 94% Success in Heart Arrhythmia Treatment - Stock Titan

Jul 01, 2025
pulisher
Jun 25, 2025

Is Stereotaxis, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Buys 36,123 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Jun 16, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Buys 5,556 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Jun 05, 2025
pulisher
May 30, 2025

Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN

May 30, 2025
pulisher
May 29, 2025

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stake Raised by Northern Trust Corp - Defense World

May 29, 2025

Stereotaxis Inc Stock (STXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$72.34
price down icon 1.28%
$189.02
price down icon 0.92%
medical_instruments_supplies BAX
$27.37
price down icon 1.44%
$63.69
price down icon 0.47%
medical_instruments_supplies COO
$71.32
price down icon 1.80%
medical_instruments_supplies WST
$210.08
price down icon 0.38%
Cap:     |  Volume (24h):